Figure PDU-1. Estimates of the prevalence of problem drug use (rate per 1 000 population aged 15 to 64), studies from 2002 to 2007 — last study available [see all figures in this series...]

Part (i) Estimates of overall problem drug use

Notes:

The term 'problem drug use' is defined in the methods and notes section.

Methods of estimation are abbreviated: CR = Capture-recapture; TM = Treatment multiplier; PM = Police multiplier; MI = Multivariate indicator; TP = Truncated Poisson; CM = Combined methods; MM = Mortality multiplier; OT = Other methods.

In the case of Germany, Finland and Spain the line given represents an interval between the lowest lower bound of all existing estimates and the highest upper bound of them.

In the case of Finland, the original age range of the study is 15 to 54 years old, in the case of Malta, the age range of the study was 12 to 64 years old, in the case of Poland the original age range of the study was all ages. Both rates was adjusted for ages 15 to 64.

Target groups may vary slightly between countries owing to different methods and data sources; therefore comparisons should be made with caution.

The symbol indicates a point estimate, a bar indicates an uncertainty interval, which can be either a 95 % confidence interval or an interval based on sensitivity analysis.

* - Central estimate was not available; a midpoint was calculated as a simple average of the low and high estimate

Related links:

Statistical bulletin 2008: Figure PDU-1 part (i)

For more details see Tables PDU-1 to PDU-3 in the Statistical bulletin 2009.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page

See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich.

Sources:

Reitox national focal points

Reitox national reports, 2008 - Fonte PDU template